Jorge Conde

At Andreessen Horowitz, we just raised over $15B. With these new funds including American Dynamism ($1.176B), Apps ($1.7B), Bio + Health ($700M), Infrastructure ($1.7B), Growth ($6.75B), and other venture strategies ($3B), we raised over 18% of all venture capital dollars allocated in the United States in 2025. Why did we raise the money and how do we plan to invest it? Read more from Ben Horowitz: a16z.news/p/we-raised-15…

@HSBCInnovation's "Next in Care: How AI is Reshaping Healthcare" (Boston) speakers are @JorgeCondeBio from @a16z, @ekelsic CEO, @Dyno_Tx), and katherine andersen (head of life sciences at hsbc). partiful.com/e/hTsMJ9EKZar9…

.@FenwickWest "From Platform to Pipeline": Cartography Bio CEO (Kevin Parker) x @JorgeCondeBio @a16z (Boston) heidi erlacher (fenwick) moderating kevin parker (CEO cartography) + jorge conde on what it actually takes to go from platform to clinic. partiful.com/e/vQDvxdHU5dZg…

We are excited to announce Biomni Lab has exited research preview and is now generally available! Over the last month, we received and incorporated valuable feedback from our global community of 10K+ scientists. We were amazed to learn that Biomni Lab power users accomplished ~20 months of work in just one. We are introducing a Pro tier (alongside the free tier) with higher usage limits, priority HPC access, and more concurrent tasks so our users can get even more done, faster. Accelerate your science today → biomni.phylo.bio

Big news! I’m joining @AsteraInstitute as CEO of Radial, their new life sciences division. How we fund, do, and build upon science has long needed an update. At Radial, we design, fund, and operate programs that tackle foundational scientific problems while simultaneously testing better ways to do science.

AI agents can execute a full biological data analysis in minutes. But in science, what matters is whether you can trust the results. With one click, Scientific Review turns Biomni Lab into its own skeptical peer reviewer, auditing its work for hallucinated claims, flawed scientific reasoning, statistical inconsistencies, and bugs in code. When issues are identified, the agent corrects them and updates the results. Built for scientific work you can trust. Try Biomni Lab: biomni.phylo.bio See Scientific Review in action🧵

We just took the guesswork out of pancreatic cancer treatment. I’m incredibly excited to share that our team’s research has been published in the @JCO_ASCO, one of the world's premier medical oncology journals. Our study proves that AI can find predictive signals in standard pathology slides in one of the hardest to treat cancers. This means we can finally match advanced pancreatic cancer patients to the chemotherapy regimen most likely to work for them—saving time when it matters most. Article: ascopubs.org/doi/10.1200/JC…

Today we’re launching Phylo, a research lab studying agentic biology, backed by a $13.5M seed round co-led by @a16z and @MenloVentures / Anthology Fund @AnthropicAI. We’re also introducing a research preview of Biomni Lab, the first Integrated Biology Environment (IBE), where we’re imagining a new way biologists work. Biomni Lab uses agents to orchestrate hundreds of biological databases, software tools, molecular AI models, expert workflows, and even external research services in one workspace, supporting research end-to-end from question to experiment to result. Agents handle the mechanics, while you define the question, then review, steer, and decide. Scientists end up spending more time on science: asking questions, understanding mechanisms, and eliminating diseases. Phylo (@phylo_bio) is a spin-out of @ProjectBiomni, where we will maintain the open-source community and push open-science research. I’m grateful to continue building with my co-founders @YuanhaoQ @jure @lecong and the dream founding team @serena2z @TianweiShe @huangzixin20151 @gm2123 @margaretwhua @malayhgandhi. We’re also fortunate to be advised by leading scientists @zhangf, Carolyn Bertozzi, and @fabian_theis, and supported by an amazing group of investors including @JorgeCondeBio @zakdoric Matt Kraning @ZettaVentures @dreidco @conviction @saranormous @svangel @valkyrie_vc and others. Biomni Lab is available for free today: biomni.phylo.bio Learn more in our launch post: phylo.bio/blog/company-f… We are also hosting launch events - join us at South San Francisco: luma.com/n8k8qb0n Virtual: luma.com/l5ryjaij We’re also hiring! phylo.bio/careers

Today we’re launching Phylo, a research lab studying agentic biology, backed by a $13.5M seed round co-led by @a16z and @MenloVentures / Anthology Fund @AnthropicAI. We’re also introducing a research preview of Biomni Lab, the first Integrated Biology Environment (IBE), where we’re imagining a new way biologists work. Biomni Lab uses agents to orchestrate hundreds of biological databases, software tools, molecular AI models, expert workflows, and even external research services in one workspace, supporting research end-to-end from question to experiment to result. Agents handle the mechanics, while you define the question, then review, steer, and decide. Scientists end up spending more time on science: asking questions, understanding mechanisms, and eliminating diseases. Phylo (@phylo_bio) is a spin-out of @ProjectBiomni, where we will maintain the open-source community and push open-science research. I’m grateful to continue building with my co-founders @YuanhaoQ @jure @lecong and the dream founding team @serena2z @TianweiShe @huangzixin20151 @gm2123 @margaretwhua @malayhgandhi. We’re also fortunate to be advised by leading scientists @zhangf, Carolyn Bertozzi, and @fabian_theis, and supported by an amazing group of investors including @JorgeCondeBio @zakdoric Matt Kraning @ZettaVentures @dreidco @conviction @saranormous @svangel @valkyrie_vc and others. Biomni Lab is available for free today: biomni.phylo.bio Learn more in our launch post: phylo.bio/blog/company-f… We are also hosting launch events - join us at South San Francisco: luma.com/n8k8qb0n Virtual: luma.com/l5ryjaij We’re also hiring! phylo.bio/careers